Halliday GM - Search Results

1

Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.

Woodhouse A, Shepherd CE, Sokolova A, Carroll VL, King AE, Halliday GM, Dickson TC, Vickers JC. Woodhouse A, et al. Among authors: halliday gm. Acta Neuropathol. 2009 Jan;117(1):19-29. doi: 10.1007/s00401-008-0458-z. Epub 2008 Nov 18. Acta Neuropathol. 2009. PMID: 19015863

2

Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation.

Halliday GM, McCann HL, Pamphlett R, Brooks WS, Creasey H, McCusker E, Cotton RG, Broe GA, Harper CG. Halliday GM, et al. Acta Neuropathol. 1992;84(6):638-50. doi: 10.1007/BF00227741. Acta Neuropathol. 1992. PMID: 1281956

3

Analysis of staining methods for different cortical plaques in Alzheimer's disease.

Halliday G, Flowers D, Baum L. Halliday G, et al. Acta Neuropathol. 1994;87(2):174-86. doi: 10.1007/BF00296188. Acta Neuropathol. 1994. PMID: 7513488

4

Practical measures to simplify the Braak tangle staging method for routine pathological screening.

Harding AJ, Kril JJ, Halliday GM. Harding AJ, et al. Among authors: halliday gm. Acta Neuropathol. 2000 Feb;99(2):199-208. doi: 10.1007/pl00007425. Acta Neuropathol. 2000. PMID: 10672328

5

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.

Halliday G, Robinson SR, Shepherd C, Kril J. Halliday G, et al. Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):1-8. doi: 10.1046/j.1440-1681.2000.03200.x. Clin Exp Pharmacol Physiol. 2000. PMID: 10696521 Review.

6

Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies.

Shepherd CE, Thiel E, McCann H, Harding AJ, Halliday GM. Shepherd CE, et al. Among authors: halliday gm. Arch Neurol. 2000 Jun;57(6):817-22. doi: 10.1001/archneur.57.6.817. Arch Neurol. 2000. PMID: 10867778

7

Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease.

Halliday GM, Shepherd CE, McCann H, Reid WG, Grayson DA, Broe GA, Kril JJ. Halliday GM, et al. Arch Neurol. 2000 Jun;57(6):831-6. doi: 10.1001/archneur.57.6.831. Arch Neurol. 2000. PMID: 10867780 Clinical Trial.

8

Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.

Shepherd CE, Thiel E, McCann H, Halliday GM. Shepherd CE, et al. Among authors: halliday gm. Neurobiol Dis. 2001 Feb;8(1):136-46. doi: 10.1006/nbdi.2000.0361. Neurobiol Dis. 2001. PMID: 11162247

9

Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies.

Broe M, Shepherd CE, Milward EA, Halliday GM. Broe M, et al. Among authors: halliday gm. Acta Neuropathol. 2001 Jun;101(6):616-24. doi: 10.1007/s004010000337. Acta Neuropathol. 2001. PMID: 11515791

10

Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.

Shepherd CE, McCann H, Thiel E, Halliday GM. Shepherd CE, et al. Among authors: halliday gm. Neurobiol Dis. 2002 Mar;9(2):249-57. doi: 10.1006/nbdi.2001.0469. Neurobiol Dis. 2002. PMID: 11895376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

755 results

Search Page

Filters